Self Monitoring of Blood Glucose (SMBG) in elderly patients with type 2 diabetes mellitus

Evaluation of the effect of Self Monitoring of Blood Glucose (SMBG) on glycosylated hemoglobin level in elderly patients with type 2 diabetes mellitus

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20171225038055N1

Enrollment

150

Registered

2018-06-05

Start date

2018-05-21

Completion date

Unknown

Last updated

2018-07-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes. Type 2 diabetes mellitus

Interventions

Intervention 1: Intervention group: Self-assessment of blood glucose in elderly diabetic patients treated with insulin . Intervention 2: Control group: Elderly diabetic patients who do not perform se

Eligibility

Sex/Gender

All

Age

60 Years to No maximum

Inclusion criteria

Inclusion criteria: Type 2 diabetes agreement to participate in the research Glycosylated hemoglobin between 7 and 9%

Exclusion criteria

Exclusion criteria: Infection with other chronic diseases including cancer, severe renal failure, severe liver and heart failure Inflammatory diseases, including rheumatoid arthritis Major Depression Other endocrine disorders, including Cushing's Blood disorders and the need for several blood transfusion

Design outcomes

Primary

Measure	Time frame
Glycosylated hemoglobin. Timepoint: Before the intervention, 120 days after self-assessment of blood glucose. Method of measurement: The test for hemoglobin A1c will be performed by chromatography.	—

Countries

Iran (Islamic Republic of)

Contacts

Public Contactatousa ariafar

Mashhad University of Medical Sciences

ariafara2@mums.ac.ir+98 51 3802 3512

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026